Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Frank, Geller; Xiaoping, Wu; Vilma, Lammi; Erik, Abner; Jesse Tyler, Valliere; Katerina, Nastou; Morten, Rasmussen; Niklas Worm, Andersson; Liam, Quinn; Bitten, Aagaard; Karina, Banasik; Sofie, Bliddal; Lasse, Boding; Søren, Brunak; Nanna, Brøns; Jonas, Bybjerg-Grauholm; Lea Arregui Nordahl, Christoffersen; Maria, Didriksen; Khoa Manh, Dinh; Christian, Erikstrup; Ulla, Feldt-Rasmussen; Kirsten, Grønbæk; Kathrine Agergård, Kaspersen; Christina, Mikkelsen; Claus Henrik, Nielsen; Henriette Svarre, Nielsen; Susanne Dam, Nielsen; Janna, Nissen; Celia Burgos, Sequeros; Niels, Tommerup; Henrik, Ullum; , FinnGen; Lampros, Spiliopoulos; Peter, Bager; Anders, Hviid; Erik, Sørensen; Ole Birger, Pedersen; Jacqueline M, Lane; Ria, Lassaunière; Hanna M, Ollila; Sisse Rye, Ostrowski; Bjarke, Feenstra

Journal title: DBDS Genomic Consortium 2024 'Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants' medRxiv. https://doi.org/10.1101/2024.11.21.24317689

Journal publisher: MedRXiv

Published year: 2024

DOI identifier: 10.1101/2024.11.21.24317689

ISSN: 3067-2007